Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.75 USD
Change Today +0.0575 / 2.14%
Volume 32.2K
ROKA On Other Exchanges
As of 5:20 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul G. Thomas

Founder, Chief Executive Officer, President and Director,Roka Bioscience, Inc.
AgeTotal Calculated CompensationThis person is connected to 28 board members in 4 different organizations across 9 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Paul G. Thomas founded Roka Bioscience, Inc., in 2009 and has been its Chief Executive Officer and President since September 2009. Mr. Thomas has an extensive background leading biotechnology companies, particularly through a variety of successful financial transactions. Mr. Thomas served as the Executive Chairman of LifeCell Corporation since June 1999 and Chief Executive Officer and President from October 1998 to August 2008. Prior to joining LifeCell, he held ...

Read Full Background

Corporate Headquarters*

20 Independence Boulevard
Warren, New Jersey 07059

United States

Phone: 908-605-4700
Fax: --

Board Members Memberships*

Founder, Chief Executive Officer, President and Director
Director, Chairman of Governance & Nominating Committee and Chairman of Regulatory & Compliance Committee
Director and Member of Audit Committee


Columbia Business School
Master's Degree
University of Georgia Graduate School of Arts and Science
Saint Michael's College

Other Affiliations*

Annual Compensation*

Total Annual Compensation$583,563

Stock Options*

All Other Compensation$25,731

Total Compensation*

Total Annual Cash Compensation$609,294
Total Short Term Compensation$583,563
Other Long Term Compensation$25,731
Total Calculated Compensation$609,294
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ROKA:US $2.75 USD +0.0575


Norman D. Schwartz Chairman, Chief Executive Officer and President
Bio-Rad Laboratories, Inc.
Ellen J. Kullman Chairwoman and Chief Executive Officer
E. I. du Pont de Nemours and Company
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
James L. Herbert Chairman and Chief Executive Officer
Neogen Corp.
Alexandre Merieux Chief Executive Officer, Director and Member of Strategy Committee
bioMérieux SA
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROKA BIOSCIENCE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at